With that staying explained, without human trials there is no way to actually evaluate how much YK11 can inhibit Myostatin in humans (if in any way), and when there is a dosage that would equate to the exact same volume of Myostatin inhibition that a genetic anomaly with a gene mutation has.If anything, phony SARMs hold the probable to be a lot mor